Details
Description
In this report, we aimed to list the most frequent diagnoses, procedures, medications and labs associated with use of inclisiran, a new molecular entity (NME) approved by the FDA in 2021 using the TriNetX Live™ platform.
We ran this query on July 25, 2024, using data from 61 health care organizations (HCOs), provided through the TriNetX Live™ platform in their USA Network with Minimal Shift from December 18, 2020 to February 29, 2024.